$1.86
0.042.2%
Last update: Nov 10, 6:34 PM
Lexicon Pharmaceuticals Inc
LXRXNASDAQ
Lexicon Pharmaceuticals rose 31.0% from $1.42 to $1.86, ahead of the S&P 500's +10.0%. Its worst day was Jan 30 (−19.4%), and its low came Jan 2 at $1.14.
Nov 10, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Lexicon Pharmaceuticals closed at its lowest level of the year, 19.7% below where the year started.
−0.9% · S&P 500 +0.2%
Lexicon Pharmaceuticals shares rose 19.1%, while the S&P 500 rose 1.2%.
Story events cover the past 12 months · Times ET
+19.1%, the year's best day · S&P 500 +1.2%
Lexicon Pharmaceuticals shares fell 19.4%, while the S&P 500 fell 0.3%.
−19.4%, the year's worst day · S&P 500 −0.3%
Lexicon Pharmaceuticals shares rose 15.2%, while the S&P 500 fell 0.3%.
+15.2% · S&P 500 −0.3%
EPS of $-0.04 beat the $-0.07 estimate on $5.5M revenue (est. $3.7M).
+0.6% · S&P 500 −0.6%
EPS of $0.00 beat the $-0.04 estimate on $1.1M revenue (est. $9.6M).
+5.0% · S&P 500 −0.3%
Lexicon Pharmaceuticals closed at its highest level of the year, 85.9% above where the year started.
+3.5% · S&P 500 +1.6%
EPS of $-0.07 missed the $-0.05 estimate on $692,000.00 revenue (est. $4.4M).
−3.7% · S&P 500 −0.2%
EPS of $-0.03 beat the $-0.05 estimate on $11.3M revenue (est. $5.5M).
+8.8% · S&P 500 −4.4%
Where it ended: a close of $1.86 on Nov 10, 2026. Up next: Q4 2026 earnings on Mar 4, 2027 (EPS est. $-0.05, revenue est. $6.4M).
Nothing in the past 12 months.
All LXRX dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LXRX and SPY from Benzinga historical bars. Not investment advice.
